Smallpox vaccine - SIGA
Latest Information Update: 23 Sep 2014
At a glance
- Originator SIGA Technologies
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Smallpox
Most Recent Events
- 31 Dec 2003 Phase-I clinical trials in Smallpox in United Kingdom (unspecified route)
- 19 Aug 2003 Preclinical trials in Smallpox in USA (unspecified route)